| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.019 | 0.9 |